Nerve damage in Mycobacterium ulcerans-infected mice: probable cause of painlessness in buruli ulcer.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  American Journal of Pathology

• Publication date

  2006-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.2353/AJPATH.2006.050375PMID 16507896PMCID PMC1606540
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Infection with Mycobacterium ulcerans Induces Persistent Inflammatory Responses in Mice

  2005cited by this paper
• Modulation of the host immune response by a transient intracellular stage of Mycobacterium ulcerans: the contribution of endogenous mycolactone toxin

  2005cited by this paper
• Analysis of Mycobacterium Species for the Presence of a Macrolide Toxin, Mycolactone

  2004cited by this paper
• Medical mystery: painless ulcers--the answer.

  2004cited by this paper
• [Comparison of inhibitory effect of rifalazil and rifampicin against Mycobacterium ulcerans infection induced in mice].

  2004cited by this paper
• Heterogeneity of Mycolactones Produced by Clinical Isolates of Mycobacterium ulcerans: Implications for Virulence

  2003cited by this paper
• Peripheral neuropathy associated with treatment for multidrug-resistant tuberculosis.

  2003cited by this paper
• Buruli ulcer disease. Mycobacterium ulcerans infection.

  2003cited by this paper
• Phenolic glycolipid-1 (PGL-1) in Buruli ulcer lesions. First demonstration by immuno-histochemistry.

  2002cited by this paper
• Bactericidal Activity of Rifampin-Amikacin against Mycobacterium ulcerans in Mice

  2002cited by this paper
• Peripheral nerve granuloma in a patient with tuberculosis

  2002cited by this paper
• In vitro activity of KRM-1648, either singly or in combination with ofloxacin, against Mycobacterium ulcerans.

  2001cited by this paper
• Activities of New Macrolides and Fluoroquinolones against Mycobacterium ulcerans Infection in Mice

  2001cited by this paper
• [A morphological study of nerve biopsies in leprous neuropathy].

  2001cited by this paper
• In vitro activity of KRM-1648, either singly or in combination with ofloxacin, against Mycobacterium ulcerans.

  2001cited by this paper
• Mycobacterium leprae typing by genomic diversity and global distribution of genotypes.

  2000cited by this paper
• A Mycobacterium ulcerans Toxin, Mycolactone, Causes Apoptosis in Guinea Pig Ulcers and Tissue Culture Cells

  2000cited by this paper
• Clinico-histopathological findings of Buruli ulcer.

  2000cited by this paper
• Role of the cell wall phenolic glycolipid-1 in the peripheral nerve predilection of Mycobacterium leprae.

  2000cited by this paper
• Mycobacterium ulcerans infection.

  1999cited by this paper
• Mycolactone: a polyketide toxin from Mycobacterium ulcerans required for virulence.

  1999cited by this paper
• Comparison of Two PCRs for Detection of Mycobacterium ulcerans

  1999cited by this paper
• Transmission of Mycobacterium ulcerans to the nine-banded armadillo.

  1999cited by this paper
• Epitope mapping of twelve monoclonal antibodies against the phenolic glycolipid-I of M. leprae.

  1997cited by this paper
• Pseudoepitheliomatous Hyperplasia In Mycobacterium Ulcerans Infection

  1996cited by this paper
• Exacerbation of isoniazid induced peripheral neuropathy by pyridoxine.

  1990cited by this paper
• An ultrastructural study of dermal nerves in early human leprosy.

  1987cited by this paper
• An ultrastructural study of dermal nerves in early human leprosy.

  1987cited by this paper
• Cytotoxic Activity of Mycobacterium ulcerans

  1974cited by this paper
• Toxin of Mycobacterium ulcerans. Production and effects in guinea pig skin.

  1974cited by this paper
• Peripheral neuropathy with ethambutol

  1972cited by this paper
• Isoniazid neuropathy in man: quantitative electron microscope study.

  1970cited by this paper
• [Bacteriology and human and experimental pathology of ulcers caused by Mycobacterium ulcerans].

  1965cited by this paper
• A new mycobacterial infection in man; cultivation of the new Mycobacterial infection in man; cultivation of the new Mycobacterium.

  1948cited by this paper
• A new mycobacterial infection in man.

  1948cited by this paper

• Buruli ulcer

  2025cites this paper
• Exploring Mycolactone—The Unique Causative Toxin of Buruli Ulcer: Biosynthetic, Synthetic Pathways, Biomarker for Diagnosis, and Therapeutic Potential

  2024cites this paper
• Exploring the Painless Nature and Potential Mechanisms of Asymptomatic Irreversible Pulpitis: A Narrative Review

  2024cites this paper
• Mycolactone: A Broad Spectrum Multitarget Antiviral Active in the Picomolar Range for COVID-19 Prevention and Cure

  2023cites this paper
• The search for a Buruli Ulcer vaccine and the effectiveness of the Bacillus Calmette-Guérin vaccine.

  2022cites this paper
• The One That Got Away: How Macrophage-Derived IL-1β Escapes the Mycolactone-Dependent Sec61 Blockade in Buruli Ulcer

  2022cites this paper
• The one that got away: how macrophage­derived IL­1beta escapes the mycolactone­dependent Sec61 blockade in Buruli Ulcer

  2022cites this paper
• Cyclosporin A as an Alternative Neuroimmune Strategy to Control Neurites and Recover Neuronal Tissues in Leprosy

  2021cites this paper
• A need for null models in understanding disease transmission: the example of Mycobacterium ulcerans (Buruli Ulcer Disease).

  2021cites this paper
• Experiences of Buruli Ulcer Patients Following Discharge in the Greater Accra Region of Ghana

  2020cites this paper
• Could Mycolactone Inspire New Potent Analgesics? Perspectives and Pitfalls

  2019cites this paper
• Mycolactone: More than Just a Cytotoxin

  2019cites this paper
• Mycolactone is toxic to cultured Schwann cells - mechanism of nerve damage in Buruli ulcer

  2019cites this paper
• Buruli Ulcer in Animals and Experimental Infection Models

  2019cites this paper
• Buruli Ulcer

  2019cites this paper
• Mycolactone as Analgesic: Subcutaneous Bioavailability Parameters

  2019cites this paper
• Communicable Diseases of the Developing World

  2018cites this paper
• Naturally occurring a loss of a giant plasmid from Mycobacterium ulcerans subsp. shinshuense makes it non-pathogenic

  2018cites this paper
• Sec61 blockade by mycolactone: A central mechanism in Buruli ulcer disease

  2018cites this paper
• The chemistry and biology of mycolactones

  2017cites this paper
• Mycolactone displays anti-inflammatory effects on the nervous system

  2017cites this paper
• Mycolactone cytotoxicity in Schwann cells could explain nerve damage in Buruli ulcer

  2017cites this paper
• Bacterial Signaling to the Nervous System through Toxins and Metabolites.

  2017cites this paper
• Investigating the mechanism behind the tissue necrosis in mycobacterium ulcerans infection.

  2017cites this paper
• Infection, Pain, and Itch

  2017cites this paper
• Mycobacterium ulcerans infection

  2017cites this paper
• Experiences of Pain and Expectations for Its Treatment Among Former Buruli Ulcer Patients.

  2016cites this paper
• Neglected Tropical Bacterial Diseases

  2016cites this paper
• Buruli ulcer in West Africa: Suffering beyond the wound

  2016cites this paper
• Mycolactone-mediated neurite degeneration and functional effects in cultured human and rat DRG neurons

  2016cites this paper
• [Mycolactone: the amazing analgesic mycobacterial toxin].

  2016cites this paper
• Assessment and Treatment of Pain during Treatment of Buruli Ulcer

  2015cites this paper
• Detection of Mycolactone by Fluorescent Thin Layer Chromatography (F-Tlc) For the Diagnosis of Buruli Ulcer

  2015cites this paper
• Psychological factors related to Buruli ulcer and tuberculosis in Sub-Saharan Africa

  2015cites this paper
• Pain Associated with Wound Care Treatment among Buruli Ulcer Patients from Ghana and Benin

  2015cites this paper
• Psychological factors related to Buruli ulcer and tuberculosis in Sub-Saharan Africa

  2015cites this paper
• Health-related quality of life of adult patients healed from Buruli ulcer in Benin.

  2015cites this paper
• Recent advances: role of mycolactone in the pathogenesis and monitoring of Mycobacterium ulcerans infection/Buruli ulcer disease

  2015influential citation
• Neurologic manifestations of the neglected tropical diseases.

  2015cites this paper
• Mycobacterial toxin induces analgesia in buruli ulcer by targeting the angiotensin pathways.

  2014influential citation
• History, biology and chemistry of Mycobacterium ulcerans infections (Buruli ulcer disease).

  2013cites this paper
• Buruli ulcer and mycolactone-producing mycobacteria.

  2013cites this paper
• Microbiological, Histological, Immunological, and Toxin Response to Antibiotic Treatment in the Mouse Model of Mycobacterium ulcerans Disease

  2013cites this paper
• Apoptosis in Buruli ulcer: a clinicopathological study of 45 cases

  2012cites this paper
• Mycobactérioses cutanées dues à Mycobacterium ulcerans, M. marinum, M. abscessus, M. chelonae et autres mycobactéries non tuberculeuses

  2011cites this paper
• Treating Mycobacterium ulcerans disease (Buruli ulcer): from surgery to antibiotics, is the pill mightier than the knife?

  2011cites this paper
• [Role of mycolactone in the nerve damage of Buruli ulcer (Mycobacterium ulcerans infection)].

  2011cites this paper
• Mycolic Acid/Cyclopropane Fatty Acid/Fatty Acid Biosynthesis and Health Relations

  2010cites this paper
• Neglected diseases caused by bacterial infections.

  2010cites this paper
• Scalable and efficient synthesis of the mycolactone core.

  2010cites this paper
• Synthetic studies on the mycolactone core.

  2010cites this paper
• Heterogeneity in the stereochemistry of mycolactones isolated from M. marinum: toxins produced by fresh vs. saltwater fish pathogens.

  2009cites this paper
• Laboratory Models of Infection and Transmission of Mycobacterium ulcerans; causative agent of Buruli ulcer disease

  2009cites this paper
• Buruli ulcer: reductive evolution enhances pathogenicity of Mycobacterium ulcerans

  2009cites this paper
• Immunosuppression and treatment-associated inflammatory response in patients with Mycobacterium ulcerans infection (Buruli ulcer)

  2009cites this paper
• Antimicrobials: Z-ring Achilles' heel for MRSA

  2008cites this paper
• Mycolactone Is Responsible for the Painlessness of Mycobacterium ulcerans Infection (Buruli Ulcer) in a Murine Study

  2008influential citation
• Subcutaneous injection of Mycobacterium ulcerans causes necrosis, chronic inflammatory response and fibrosis in skeletal muscle.

  2008cites this paper
• The dermatopathology of new and emerging infectious diseases.

  2007cites this paper
• Mycobacterium leprae in Neurons of the Medulla Oblongata and Spinal Cord in Leprosy

  2007cites this paper
• Early trafficking events of Mycobacterium ulcerans within Naucoris cimicoides

  2007cites this paper
• ブルーリ潰瘍（Mycobacterium ulcerans感染症）の神経傷害におけるmycolactoneの役割

  2007cites this paper
• Clinical and Histopathological Presentation of Buruli Ulcer in Experimentally Infected Grasscutters (Thryonomys swinderianus)

  2006cites this paper